Human immunodeffciency virus and pregnancy

Archives of Gynecology and Obstetrics

Volumn 281, Issue 5, 2010, Pages 781-792

  Reshi, Parveen ^a   Lone, Iqbal M ^b  

^a GOVERNMENT MEDICAL COLLEGE   (India)

^b SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

HAART; HIV; Management; Pregnancy; Transmission; Viral load

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; CHEMOKINE RECEPTOR ANTAGONIST; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; ENFUVIRTIDE; FOLIC ACID; FOSAMPRENAVIR; HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR; HYDROXYUREA; INDINAVIR; LAMIVUDINE; LOPINAVIR; METHYLERGOMETRINE MALEATE; NELFINAVIR; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR; UNINDEXED DRUG; ZALCITABINE; ZIDOVUDINE; METHYLERGOMETRINE; OXYTOCIC AGENT;

CESAREAN SECTION; CONCEPTION; CONGENITAL MALFORMATION; DELIVERY; DRUG CLEARANCE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; INFECTION PREVENTION; INFERTILITY THERAPY; LACTIC ACIDOSIS; LIFE EXPECTANCY; LIPODYSTROPHY; MORBIDITY; MORTALITY; NONHUMAN; PATIENT MONITORING; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; PRESCRIPTION; PREVALENCE; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; REVIEW; RISK ASSESSMENT; SCREENING; SEXUAL INTERCOURSE; SOCIAL PSYCHOLOGY; SPERM; VIRUS INHIBITION; VIRUS LOAD; VIRUS TRANSMISSION; ANTIVIRAL RESISTANCE; ARTIFICIAL INSEMINATION; DISEASE TRANSMISSION; FEMALE; PREGNANCY COMPLICATION;

ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CESAREAN SECTION; DRUG RESISTANCE, VIRAL; FEMALE; HIV INFECTIONS; HUMANS; INSEMINATION, ARTIFICIAL, HOMOLOGOUS; METHYLERGONOVINE; OXYTOCICS; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRAL LOAD;

EID: 77950628319     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-009-1334-3     Document Type: Review

References (23)

1. Working Group on Mother-To-Child Transmission of HIV (1995) Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. J Acquir Immune Defic Syndr Hum Retrovirol 8:506-510
2. Garcia PM, Kalish LA, Pitt J, MinkoV H, Quinn TC, Burchett SK et al (1999) Maternal levels of plasma human immunodeffciency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 341:394-402
3. Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA, Whitehouse J et al (1999) Risk factors for perinatal transmission of human immunodeffciency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med 341:385-393
4. Kourtis AP, Bulterys M, Nesheim SR, Lee FK (2001) Understanding the timing of HIV transmission from mother to infant. JAMA 285:709-712
5. Mandelbrot L, Jasseron C, Ekoukou D, Batallan A, Bongain A, Pannier E et al (2009) Amniocentesis and mother-to-child human immunodeffciency virus transmission in the Agence Nationale de Recherches sur le SIDA et les Hépatites Virales French Perinatal Cohort. Am J Obstet Gynecol 200:160e1-160e9
6. Cavert W, Notermans DW, Stakus K et al (1997) Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 276:960-964
7. Zhang L, Ramratnam B, Tenner-Racz K et al (1999) Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N Engl J Med 340:1605-1613
8. Fakoya A, Lamba H, Mackie N, Nandwani R, Brown A, Bernard EJ, Gilling-Smith C, Lacey C, Sherr L, Claydon P, Wallage S, Gazzard B (2008) British HIV association. BASSH and FSRH guidelines for the management of the sexual and reproductive health of people living with HIV-infection 2008. HIV Med 9:681-720
9. Little SJ, Holte S, Routy JP et al (2002) Antiretroviral drug resistance among patients recently infected with HIV. N Engl J Med 347(6):385-394
10. Richman DD, Morton SC, Wrin T et al (2004) The prevalence of antiretroviral drug resistance in the United States. AIDS 18(10):1393-1401
11. Lyall EG, Blott M, de Ruiter A, Hawkins D, Mercy D, Mitchla Z et al (2001) Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. HIV Med 2:314-334
12. Boer K, Nellen JF, Patel D, Timmermans S, Tempelman C, Wibaut M, Sluman MA, van der Ende ME, Godfried MH (2007) The AmRo study: pregnancy outcome in HIV-1-infected women under eVective highly active antiretroviral therapy and a policy of vaginal delivery. BJOG 114(2):148-155
13. Fiore S, Newell ML, Thorne C et al (2004) Higher rates of postpartum complications in HIV-infected than in uninfected women irrespective of mode of delivery. AIDS 18(6):933-938
14. Semprini AE, Castagna C, Ravizza M et al (1995) The incidence of complications after caesarean section in 156 HIV-positive women. AIDS 9(8):913-917
15. Fiore S (1999) Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. The European Mode of Delivery Collaboration. Lancet 353(9158):1035-1039
16. Kind C, Rudin C, Siegrist CA et al (1998) Prevention of vertical HIV transmission: additive protective eVect of elective cesarean section and zidovudine prophylaxis. AIDS 12(2):205-210
17. Semprini AE, Fiore S (2004) HIV and reproduction. Curr Opin Obstet Gynecol 16:257-262
18. Gilling-Smith C (2001) Assisted reproduction in HIV discordant couples. AIDS Reader 10:581-587
19. Ohl J, Partisani M, Wittemer C et al (2003) Assisted reproduction techniques for HIV serodiscordant couples: 18 months of experience. Hum Reprod 18:1244-1249
20. Connor EM, Sperling RS, Gelber R et al (1994) Reduction of maternal-infant transmission of human immunodeffciency virus type 1 with zidovudine treatment. N Engl J Med 331(18):1173-1180
21. Semprini AE, Castagna C, Ravizza M, Fiore S, Savasi V, Muggiasca ML et al (1995) The incidence of complications after caesarean section in 156 HIV positive women. AIDS 9:913-917
22. Sauer MV, Chang PL (2002) Establishing a clinical program to assist HIV-1 seropositive men to have children using IVF-ICSI. Am J Obstet Gynaecol 186:627-633
23. Gilling-Smith C (2006) Fertility management of HIV couples. Curr Obstet Gynaecol 16:299-305